The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Five‐year follow‐up of health‐related quality of life after primary treatment of localized prostate cancer
Abstract
Although with earlier detection of prostate cancer more men face the long‐term consequences of primary treatment, studies on the impact of treatment on long‐term health‐related quality of life (HRQoL) are scarce. We followed 314 men with newly diagnosed localized prostate cancer from 1 month before until 5 years after radical prostatectomy (n = 127) or external beam radiotherapy (n = 187; median follow‐up = 52 months). Questionnaires addressing disease‐specific (UCLA PCI) and generic (SF‐36, EQ‐5D) HRQoL were sent 1 month before and 6, 12 and 52 months after treatment. Repeated‐measures modeling was used to study HRQoL over time. Regular urinary leakage was reported by 12% of prostatectomy patients before treatment and by 31% at the 52‐month assessment. Erectile dysfunction before treatment was reported by 31% of prostatectomy patients and by 40% of radiotherapy patients; at the 52‐month assessment, these percentages were 88% and 64%, respectively. Erectile dysfunction present at 1 year posttreatment can be considered permanent. Prostatectomy patients reported better generic functioning both before and after treatment than radiotherapy patients, who were on average 5.9 years older and had more comorbid conditions. General physical functioning of prostatectomy patients slightly improved over time, but declined in radiotherapy patients. The relation between age and physical scores was found to be nonlinear. The long‐term physical decline in radiotherapy patients partly resulted from aging and its nonlinear impact on health, although treatment effects cannot be excluded. Scores of both patient groups remained above those of norm populations. Innovative graphs describing disease‐specific and generic functions after treatment can help patients and physicians in their treatment choices. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
Self-citationIntegrating response shift into health-related quality of life research: a theoretical model
Sprangers, M. A. G., & Schwartz, C. E. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00045-3 · Cited by 2,228 · cited 1×
“Possible explanations for the higher generic scores after treatment include insensitivity of generic instruments for changes induced by prostate cancer diagnosis and treatment and response shift.(32) Patients may reevaluate the value of life itself when (after intentionally curative treatment for cancer) they are stil…”
BackgroundDonovan, J., Little, P., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., Frankel, S., Neal, D., & Hamdy, F. (2002) · BMJ · doi:10.1136/bmj.325.7367.766 · Cited by 533
Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003) · Medical Care · doi:10.1097/00005650-200301000-00017 · Cited by 119
Cited by
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Self-citationQuality-of-Life Effects of Prostate-Specific Antigen Screening
Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201637 · Cited by 427
Self-citationRecommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Reeve, B. B., Mitchell, S. A., Dueck, A. C., Basch, E., Cella, D., Reilly, C. M., Minasian, L. M., Denicoff, A. M., O'Mara, A. M., Fisch, M. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju129 · Cited by 350
Quality of life in “chronic” cancer survivors: a meta-analysis
Firkins, J., Hansen, L., Driessnack, M., & Dieckmann, N. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00869-9 · Cited by 290
Smith, D. P., King, M. T., Egger, S., Berry, M. P., Stricker, P. D., Cozzi, P., Ward, J., O'Connell, D. L., & Armstrong, B. K. (2009) · BMJ · doi:10.1136/bmj.b4817 · Cited by 286
Health Utilities Using the EQ-5D in Studies of Cancer
Pickard, A. S., Wilke, C. T., Lin, H.-W., & Lloyd, A. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725050-00002 · Cited by 285
Dubbelman, Y. D., Dohle, G. R., & Schröder, F. H. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.009 · Cited by 222
Self-citationImpact of Cancer on Health-Related Quality of Life of Older Americans
Reeve, B. B., Potosky, A. L., Smith, A. W., Han, P. K., Hays, R. D., Davis, W. W., Arora, N. K., Haffer, S. C., & Clauser, S. B. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp123 · Cited by 211
Does “normal” aging imply urinary, bowel, and erectile dysfunction? A general population survey
Korfage, I. J., Roobol, M., de Koning, H. J., Kirkels, W. J., Schröder, F. H., & Essink-Bot, M.-L. (2008) · Urology · doi:10.1016/j.urology.2008.01.058 · Cited by 45
Self-citationPenedo, F. J., Benedict, C., Zhou, E. S., Rasheed, M., Traeger, L., Kava, B. R., Soloway, M., Czaja, S., & Antoni, M. H. (2013) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-012-9308-1 · Cited by 25
Mc Caughan, E., Mc Sorley, O., Prue, G., Parahoo, K., Bunting, B., Sullivan, J. O., & McKenna, H. (2013) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2012.05987.x · Cited by 23
Metadata
- Authors
- Korfage, I. J., Essink‐Bot, M., Borsboom, G. J. J. M., Madalinska, J. B., Kirkels, W. J., Habbema, J. D. F., Schröder, F. H., & de Koning, H. J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2005-03-30
- Volume
- 116
- Issue
- 2
- Pages
- 291-296
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1979842176
- Cited by
- 195
- References
- 4
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.